Strategies targeting the NO pathway to counteract extra-pulmonary manifestations of COPD: A systematic review and meta-analysis.
Beetroot juice
COPD
Exercise
Nitrate
Nitric oxide
Journal
Nitric oxide : biology and chemistry
ISSN: 1089-8611
Titre abrégé: Nitric Oxide
Pays: United States
ID NLM: 9709307
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
received:
22
04
2022
revised:
01
07
2022
accepted:
10
08
2022
pubmed:
18
8
2022
medline:
14
9
2022
entrez:
17
8
2022
Statut:
ppublish
Résumé
The clinical symptoms of chronic obstructive pulmonary disease (COPD) disease are accompanied by severely debilitating extra-pulmonary manifestations, including vascular dysfunction and hypertension. This systematic review evaluated the current evidence for several therapeutic interventions, targeting the nitric oxide (NO) pathway on hemodynamics and, secondarily, exercise capacity in patients with COPD. A comprehensive search on COPD and NO donors was performed on online databases. Of 934 initially found manuscripts, 27 were included in the review, and 16 in the meta-analysis. The analysis indicated inconsistent effects of dietary nitrate supplementation on exercise tolerance in COPD patients. Dietary nitrate supplementation decreased systolic (-3.7 ± 4.3 mmHg; p = 0.10) and diastolic blood pressure (BP; -2.6 ± 3.2 mmHg; p = 0.05) compared with placebo. When restricted to acute studies, a clinically relevant BP lowering effect of nitrate supplementation during diastole was observed (-4.7 ± 3.2 mmHg; n = 5; p = 0.05). In contrast, inhaled NO (iNO) at doses <20 ppm (+9.2 ± 11.3 mmHg) and 25-40 ppm (-5±2 mmHg) resulted in inconsistent effects on PaO
Identifiants
pubmed: 35977691
pii: S1089-8603(22)00087-8
doi: 10.1016/j.niox.2022.08.004
pii:
doi:
Substances chimiques
Nitrates
0
Nitrogen Oxides
0
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
59-71Subventions
Organisme : NHLBI NIH HHS
ID : R00 HL125756
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.